生細胞イメージングの世界市場 (～2030年)：製品 (装置・消耗品・ソフトウェア・サービス)・用途 (細胞生物学・幹細胞・創薬)・技術 (タイムラプス顕微鏡・FRET・FRAP・HCS)・エンドユーザー (製薬・バイオテクノロジー・CRO) 別

世界の生細胞イメージングの市場規模は、2025年の31億3,000万米ドルから、予測期間中はCAGR 8.68％で推移し、2030年には47億5,000万米ドルに達すると予測されています。

イメージング技術の継続的な進歩および世界的な癌症例の増加が同市場の成長を支える要因となっています。さらに、細胞生物学研究への資金や助成金の利用可能性、創薬や研究におけるHCS技術の採用拡大が生細胞製品および消耗品に対する需要を高めており、市場の成長を後押ししています。主要企業は、生細胞イメージング分野における新たな成長機会を獲得するために新興市場への展開を進めていますが、機器の高コストがこの展開を制限しており、これらの製品は小規模な学術機関や製薬会社には手が届きにくい状況となっています。

提供区分別では、解析ソフトウェアの部門が予測期間中に最大の成長が見込まれています。この大きな成長は、細胞研究における高度なデータ解析、自動化、AI統合に対する需要の高まりに起因しています。イメージング技術が高度化するにつれ、研究者は膨大かつ複雑な画像データを管理し、リアルタイムで解析し、生物学的に有意な知見を抽出するための強力なソフトウェアツールを必要としています。また、ハイコンテントスクリーニング、3Dイメージング、タイムラプス顕微鏡の普及も、多次元データセットに対応可能なインテリジェントソフトウェアの需要をさらに押し上げています。加えて、機械学習やディープラーニングアルゴリズムの統合により、細胞のセグメンテーション（領域分割）、トラッキング、フェノタイピング（表現型の解析）がより迅速かつ正確に行えるようになり、これらのツールは創薬、癌研究、再生医療において不可欠な存在となっています。

エンドユーザー別では、製薬＆バイオテクノロジー企業が2024年に最大のシェアを示しています。この大きなシェアは、創薬、細胞生物学研究、個別化医療における高度なイメージング技術の需要増に起因しています。これらの企業は、細胞の挙動を観察し、疾病メカニズムを研究し、潜在的な薬剤候補の効果をリアルタイムで評価することにおいて、生細胞イメージングに大きく依存しています。慢性疾患の増加や正確な治療に対するニーズの高まりが、これらの分野での生細胞イメージング技術の採用をさらに後押ししています。この動向は予測期間中も続くと予想され、その背景にはイメージング技術における継続的な技術革新、より迅速で正確な医薬品開発の必要性、治療開発における細胞研究の重要性の高まりがあります。

地域別では、アジア太平洋地域がもっと最も急成長している地域であり、予測期間中は最大のCAGRを示す見通しです。この成長の原動力は、ヘルスケアとバイオテクノロジー分野への投資の増加と、先端イメージング技術への需要の高まりです。中国、日本、インドでは研究開発活動が活発化しており、特に創薬や再生医療では高度なイメージング技術が必要とされています。さらに、科学研究に対する政府の支援や個別化医療への注目の高まりも、この地域におけるこの市場の成長を後押しする主な要因となっています。

当レポートでは、世界の生細胞イメージングの市場を調査し、市場概要、市場成長への各種影響因子の分析、技術・特許の動向、法規制環境、ケーススタディ、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
• 顧客の事業に影響を与える動向/ディスラプション
• 価格分析
• バリューチェーン分析
• エコシステム分析
• 投資および資金調達活動
• 技術分析
• 特許分析
• 貿易データ分析
• 主な会議とイベント
• 規制状況
• ポーターのファイブフォース分析
• 主要なステークホルダーと購入基準
• AI/生成AIが生細胞イメージング市場に与える影響
• 2025年の米国関税が生細胞イメージング市場に与える影響

第6章 生細胞イメージング市場：提供内容別

• 製品
  • 機器
  • 消耗品
• ソフトウェア
• サービス

第7章 生細胞イメージング市場：技術別

• タイムラプス顕微鏡
• 蛍光共鳴エネルギー移動
• 光退色後の蛍光回復
• ハイコンテンツスクリーニング
• その他

第8章 生細胞イメージング市場：用途別

• 細胞生物学研究
• 創薬
• 幹細胞研究
• 発生生物学研究

第9章 生細胞イメージング市場：エンドユーザー別

• 製薬・バイオテクノロジー企業
• 学術研究機関
• CRO

第10章 生細胞イメージング市場：地域別

• 北米
  • マクロ経済分析
  • 米国
  • カナダ
• 欧州
  • マクロ経済見通し
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • マクロ経済見通し
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • その他
• ラテンアメリカ
  • マクロ経済見通し
  • ブラジル
  • メキシコ
  • その他
• 中東
  • マクロ経済見通し
  • GCC諸国
  • その他
• アフリカ
  • マクロ経済見通し

第11章 競合情勢

• 主要企業の戦略/有力企業
• 収益分析
• 市場シェア分析
• 企業評価と財務指標
• ブランド/製品比較
• 企業評価マトリックス：主要企業
• 主要企業の企業フットプリント
• 企業評価マトリックス：スタートアップ/中小企業
• 競合ベンチマーキング：スタートアップ/中小企業
• 競合シナリオ

第12章 企業プロファイル

• 主要企業
  • DANAHER
  • ZEISS GROUP
  • THERMO FISHER SCIENTIFIC INC.
  • REVVITY
  • SARTORIUS AG
  • NIKON CORPORATION
  • EVIDENT
  • AGILENT TECHNOLOGIES, INC.
  • NANOENTEK
  • BRUKER
  • BD
  • MERCK KGAA
  • BIO-RAD LABORATORIES, INC.
  • TECAN TRADING AG
  • SYSMEX CORPORATION
  • CORNING INCORPORATED
• その他の企業
  • AXION BIOSYSTEMS, INC.
  • BLUE-RAY BIOTECH CORP.
  • CURIOSIS INC.
  • CYTENA GMBH
  • ABBERIOR GMBH
  • PHASE HOLOGRAPHIC IMAGING PHI AB
  • ALIGNED GENETICS INC.
  • CHERRY BIOTECH
  • NANOLIVE SA
  • CYTOTRONICS
  • ETALUMA, INC.
  • TISSUEGNOSTICS GMBH

第13章 付録

List of Tables

• TABLE 1 LIVE CELL IMAGING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
• TABLE 2 ESTIMATED NEW CANCER CASES IN US, 2025
• TABLE 3 AVERAGE SELLING PRICE TREND OF LIVE CELL IMAGING PRODUCTS, BY KEY PLAYER, 2022-2024
• TABLE 4 AVERAGE SELLING PRICE, BY REGION, 2024
• TABLE 5 LIVE CELL IMAGING MARKET: ROLE OF COMPANIES IN ECOSYSTEM
• TABLE 6 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014-2025
• TABLE 7 LIVE CELL IMAGING MARKET: PATENT ANALYSIS, 2024
• TABLE 8 IMPORT DATA FOR LIVE CELL IMAGING PRODUCTS (HS CODE 901120), BY COUNTRY, 2020-2024 (USD THOUSAND)
• TABLE 9 EXPORT DATA FOR HS CODE 901120, BY COUNTRY, 2020-2024 (USD THOUSAND)
• TABLE 10 LIVE CELL IMAGING MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
• TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 14 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 15 LIVE CELL IMAGING MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
• TABLE 17 BUYING CRITERIA, BY END USER
• TABLE 18 US ADJUSTED RECIPROCAL TARIFF RATES
• TABLE 19 LIVE CELL IMAGING PRODUCT-RELATED TARIFF REVISION
• TABLE 20 IMPACT OF US TARIFF ON END-USE APPLICATIONS OF LIVE CELL IMAGING PRODUCTS
• TABLE 21 LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 22 INSTRUMENTS OFFERED BY KEY MARKET PLAYERS
• TABLE 23 LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 24 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 25 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 26 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 27 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENT MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 28 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 29 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 30 LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 31 LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 32 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 33 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 34 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 35 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 36 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 37 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 38 CELL IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS
• TABLE 39 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 40 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 41 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 42 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 43 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 44 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 45 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL IMAGING SYSTEMS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 46 CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS
• TABLE 47 LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 48 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 49 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 50 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 51 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 52 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 53 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 54 ACCESSORIES OFFERED BY KEY MARKET PLAYERS
• TABLE 55 LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 56 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 57 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 58 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 59 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 60 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENT MARKET FOR ACCESSORIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 61 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENT MARKET FOR ACCESSORIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 62 LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 63 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 64 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 65 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 66 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 67 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 68 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 69 LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 70 REAGENTS OFFERED BY KEY MARKET PLAYERS
• TABLE 71 LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 72 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 73 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 74 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 75 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 76 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 77 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 78 ASSAY KITS OFFERED BY KEY MARKET PLAYERS
• TABLE 79 LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 80 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 81 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 82 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLE MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 83 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 84 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 85 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 86 MEDIA OFFERED BY KEY MARKET PLAYERS
• TABLE 87 LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2023-2030 (USD MILLION)
• TABLE 88 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 89 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 90 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 91 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 92 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2023-2030 (USD MILLION)
• TABLE 93 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLE MARKET FOR MEDIA, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 94 OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS
• TABLE 95 OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 96 NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 97 EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 98 ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 99 LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 100 MIDDLE EAST: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 101 GCC COUNTRIES: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 102 SOFTWARE OFFERED BY KEY MARKET PLAYERS
• TABLE 103 LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 104 NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 105 EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 106 ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 107 LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 108 MIDDLE EAST: LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 109 GCC COUNTRIES: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 110 LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 111 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 112 EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 113 ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 114 LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 115 MIDDLE EAST: LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 116 GCC COUNTRIES: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 117 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 118 LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 119 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 120 EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 121 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 122 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 123 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 124 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 125 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 126 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 127 EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 128 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 129 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 130 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 131 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 132 LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 133 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 134 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 135 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 136 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 137 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 138 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING TECHNOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 139 LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2023-2030 (USD MILLION)
• TABLE 140 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 141 EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 142 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 143 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 144 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2023-2030 (USD MILLION)
• TABLE 145 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 146 LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 147 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 148 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 149 ASIA PACIFIC: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 150 LATIN AMERICA: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 151 MIDDLE EAST: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 152 GCC COUNTRIES: OTHER LIVE CELL IMAGING TECHNOLOGIES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 153 LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 154 LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY REGION, 2023-2030 (USD MILLION)
• TABLE 155 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 156 EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 157 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 158 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 159 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY REGION, 2023-2030 (USD MILLION)
• TABLE 160 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 161 LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 162 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 163 EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 164 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 165 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 166 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 167 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 168 LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY REGION, 2023-2030 (USD MILLION)
• TABLE 169 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 170 EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 171 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 172 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 173 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY REGION, 2023-2030 (USD MILLION)
• TABLE 174 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 175 LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 176 NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 177 EUROPE: LIVE CELL IMAGING SERVICES MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 178 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 179 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 180 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2023-2030 (USD MILLION)
• TABLE 181 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 182 LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 183 LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 184 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 185 EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 186 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 187 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 188 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 189 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 190 LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 191 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 192 EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 193 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 194 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 195 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
• TABLE 196 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 197 LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 198 NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 199 EUROPE: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 200 ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 201 LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 202 MIDDLE EAST: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2023-2030 (USD MILLION)
• TABLE 203 GCC COUNTRIES: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 204 LIVE CELL IMAGING MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 205 NORTH AMERICA: KEY MACROECONOMIC INDICATORS
• TABLE 206 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 207 NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 208 NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 209 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 210 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 211 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 212 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 213 US: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 214 US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 215 US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 216 US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 217 US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 218 US: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 219 CANADA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 220 CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 221 CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 222 CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 223 CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 224 CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 225 EUROPE: KEY MACROECONOMIC INDICATORS
• TABLE 226 EUROPE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 227 EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 228 EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 229 EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 230 EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 231 EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 232 EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 233 GERMANY: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 234 GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 235 GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 236 GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 237 GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 238 GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 239 UK: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 240 UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 241 UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 242 UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 243 UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 244 UK: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 245 FRANCE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 246 FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 247 FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 248 FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 249 FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 250 FRANCE: LIVE CEL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 251 ITALY: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 252 ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 253 ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 254 ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 255 ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 256 ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 257 SPAIN: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 258 SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 259 SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 260 SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 261 SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 262 SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 263 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 264 REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 265 REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 266 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 267 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 268 REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 269 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
• TABLE 270 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 271 ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 272 ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 273 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 274 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 275 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 276 ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 277 CHINA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 278 CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 279 CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 280 CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 281 CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 282 CHINA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 283 JAPAN: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 284 JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 285 JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 286 JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 287 JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 288 JAPAN: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 289 INDIA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 290 INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 291 INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 292 INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 293 INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 294 INDIA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 295 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 296 SOUTH KOREA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 297 SOUTH KOREA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 298 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 299 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 300 SOUTH KOREA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 301 AUSTRALIA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 302 AUSTRALIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 303 AUSTRALIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 304 AUSTRALIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 305 AUSTRALIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 306 AUSTRALIA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 307 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 308 REST OF ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 309 REST OF ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 310 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 311 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 312 REST OF ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 313 LATIN AMERICA: KEY MACROECONOMIC INDICATORS
• TABLE 314 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 315 LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 316 LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 317 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 318 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 319 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 320 LATIN AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 321 BRAZIL: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 322 BRAZIL: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 323 BRAZIL: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 324 BRAZIL: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 325 BRAZIL: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 326 BRAZIL: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 327 MEXICO: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 328 MEXICO: LIVE CELL IMAGING INSTRUMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 329 MEXICO: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 330 MEXICO: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 331 MEXICO: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 332 MEXICO: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 333 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 334 REST OF LATIN AMERICA: LIVE CELL IMAGING INSTRUMENT MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 335 REST OF LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 336 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 337 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 338 REST OF LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 339 MIDDLE EAST: KEY MACROECONOMIC INDICATORS
• TABLE 340 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 341 MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 342 MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 343 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 344 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 345 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 346 MIDDLE EAST: LIVE CELL IMAGING MARKET, BY REGION, 2023-2030 (USD MILLION)
• TABLE 347 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 348 GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 349 GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 350 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 351 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 352 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 353 GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
• TABLE 354 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 355 SAUDI ARABIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 356 SAUDI ARABIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 357 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 358 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 359 SAUDI ARABIA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 360 UAE: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 361 UAE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 362 UAE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 363 UAE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 364 UAE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 365 UAE: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 366 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 367 REST OF GCC COUNTRIES: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 368 REST OF GCC COUNTRIES: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 369 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 370 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 371 REST OF GCC COUNTRIES: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 372 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 373 REST OF MIDDLE EAST: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 374 REST OF MIDDLE EAST: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 375 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 376 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 377 REST OF MIDDLE EAST: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 378 AFRICA: KEY MACROECONOMIC INDICATORS
• TABLE 379 AFRICA: LIVE CELL IMAGING MARKET, BY OFFERING, 2023-2030 (USD MILLION)
• TABLE 380 AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 381 AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2023-2030 (USD MILLION)
• TABLE 382 AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
• TABLE 383 AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
• TABLE 384 AFRICA: LIVE CELL IMAGING MARKET, BY END USER, 2023-2030 (USD MILLION)
• TABLE 385 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN LIVE CELL IMAGING MARKET, 2022-2025
• TABLE 386 LIVE CELL IMAGING MARKET: DEGREE OF COMPETITION
• TABLE 387 LIVE CELL IMAGING MARKET: REGION FOOTPRINT
• TABLE 388 LIVE CELL IMAGING MARKET: OFFERING FOOTPRINT
• TABLE 389 LIVE CELL IMAGING MARKET: APPLICATION FOOTPRINT
• TABLE 390 LIVE CELL IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 391 LIVE CELL IMAGING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
• TABLE 392 LIVE CELL IMAGING MARKET: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-APRIL 2025
• TABLE 393 LIVE CELL IMAGING MARKET: DEALS, JANUARY 2022-APRIL 2025
• TABLE 394 LIVE CELL IMAGING MARKET: EXPANSIONS, JANUARY 2022-APRIL 2025
• TABLE 395 DANAHER: COMPANY OVERVIEW
• TABLE 396 DANAHER: PRODUCTS OFFERED
• TABLE 397 DANAHER: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-APRIL 2025
• TABLE 398 DANAHER: DEALS, JANUARY 2022-APRIL 2025
• TABLE 399 ZEISS GROUP: COMPANY OVERVIEW
• TABLE 400 ZEISS GROUP: PRODUCTS OFFERED
• TABLE 401 ZEISS GROUP: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-APRIL 2025
• TABLE 402 ZEISS GROUP: DEALS, JANUARY 2022-APRIL 2025
• TABLE 403 ZEISS GROUP: EXPANSIONS, JANUARY 2022-APRIL 2025
• TABLE 404 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
• TABLE 405 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
• TABLE 406 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022-APRIL 2025
• TABLE 407 REVVITY: COMPANY OVERVIEW
• TABLE 408 REVVITY: PRODUCTS OFFERED
• TABLE 409 REVVITY: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-APRIL 2025
• TABLE 410 SARTORIUS AG: COMPANY OVERVIEW
• TABLE 411 SARTORIUS AG: PRODUCTS OFFERED
• TABLE 412 SARTORIUS AG: DEALS, JANUARY 2022-APRIL 2025
• TABLE 413 NIKON CORPORATION: COMPANY OVERVIEW
• TABLE 414 NIKON CORPORATION: PRODUCTS OFFERED
• TABLE 415 NIKON CORPORATION: EXPANSIONS, JANUARY 2022-APRIL 2025
• TABLE 416 EVIDENT: COMPANY OVERVIEW
• TABLE 417 EVIDENT: PRODUCTS OFFERED
• TABLE 418 EVIDENT: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022- APRIL 2025
• TABLE 419 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
• TABLE 420 AGILENT TECHNOLOGIES, INC: PRODUCTS OFFERED
• TABLE 421 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022-APRIL 2025
• TABLE 422 NANOENTEK: COMPANY OVERVIEW
• TABLE 423 NANOENTEK INC.: PRODUCTS OFFERED
• TABLE 424 BRUKER: COMPANY OVERVIEW
• TABLE 425 BRUKER: PRODUCTS OFFERED
• TABLE 426 BRUKER: DEALS, JANUARY 2022-APRIL 2025
• TABLE 427 BD: COMPANY OVERVIEW
• TABLE 428 BD: PRODUCTS OFFERED
• TABLE 429 MERCK KGAA: COMPANY OVERVIEW
• TABLE 430 MERCK KGAA: PRODUCTS OFFERED
• TABLE 431 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
• TABLE 432 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
• TABLE 433 TECAN TRADING AG: COMPANY OVERVIEW
• TABLE 434 TECAN TRADING AG: PRODUCTS OFFERED
• TABLE 435 SYSMEX CORPORATION: COMPANY OVERVIEW
• TABLE 436 SYSMEX CORPORATION: PRODUCTS OFFERED
• TABLE 437 CORNING INCORPORATED: COMPANY OVERVIEW
• TABLE 438 CORNING INCORPORATED: PRODUCTS OFFERED
• TABLE 439 AXION BIOSYSTEMS, INC.: COMPANY OVERVIEW
• TABLE 440 BLUE-RAY BIOTECH CORP.: COMPANY OVERVIEW
• TABLE 441 CURIOSIS INC.: COMPANY OVERVIEW
• TABLE 442 CYTENA GMBH: COMPANY OVERVIEW
• TABLE 443 ABBERIOR GMBH: COMPANY OVERVIEW
• TABLE 444 PHASE HOLOGRAPHIC IMAGING PHI AB: COMPANY OVERVIEW
• TABLE 445 ALIGNED GENETICS INC.: COMPANY OVERVIEW
• TABLE 446 CHERRY BIOTECH: COMPANY OVERVIEW
• TABLE 447 NANOLIVE SA: COMPANY OVERVIEW
• TABLE 448 CYTOTRONICS: COMPANY OVERVIEW
• TABLE 449 ETALUMA, INC.: COMPANY OVERVIEW
• TABLE 450 TISSUEGNOSTICS GMBH: COMPANY OVERVIEW

List of Figures

• FIGURE 1 LIVE CELL IMAGING MARKET SEGMENTATION
• FIGURE 2 RESEARCH DESIGN
• FIGURE 3 LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
• FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2024
• FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024
• FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER: REVENUE SHARE ANALYSIS, 2024
• FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY EXPERTS
• FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• FIGURE 9 LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2025-2030
• FIGURE 10 LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF MARKET DYNAMICS
• FIGURE 11 DATA TRIANGULATION METHODOLOGY
• FIGURE 12 LIVE CELL IMAGING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
• FIGURE 13 LIVE CELL IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
• FIGURE 14 LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
• FIGURE 15 LIVE CELL IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
• FIGURE 16 LIVE CELL IMAGING MARKET: GEOGRAPHICAL SNAPSHOT
• FIGURE 17 GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET
• FIGURE 18 INSTRUMENTS SEGMENT AND US DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 2024
• FIGURE 19 INSTRUMENTS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030
• FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
• FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN LIVE CELL IMAGING MARKET FROM 2025 TO 2030
• FIGURE 22 LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 23 GLOBAL CANCER INCIDENCE AND MORTALITY, 2022
• FIGURE 24 REVENUE SHIFT FOR PLAYERS IN LIVE CELL IMAGING MARKET
• FIGURE 25 AVERAGE SELLING PRICE TREND OF LIVE CELL IMAGING PRODUCTS, BY KEY PLAYER, 2022-2024
• FIGURE 26 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024
• FIGURE 27 LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS
• FIGURE 28 LIVE CELL IMAGING MARKET: ECOSYSTEM ANALYSIS
• FIGURE 29 PATENT ANALYSIS OF LIVE CELL IMAGING MARKET, JANUARY 2014-APRIL 2025
• FIGURE 30 LIVE CELL IMAGING MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
• FIGURE 32 KEY BUYING CRITERIA, BY END USER
• FIGURE 33 NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT
• FIGURE 34 ASIA PACIFIC: LIVE CELL IMAGING MARKET SNAPSHOT
• FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS, 2022-2024 (USD MILLION)
• FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
• FIGURE 37 EV/EBITDA OF KEY PLAYERS, 2025
• FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY PLAYERS, 2025
• FIGURE 39 LIVE CELL IMAGING MARKET: BRAND/PRODUCT COMPARISON
• FIGURE 40 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
• FIGURE 41 LIVE CELL IMAGING MARKET: COMPANY FOOTPRINT
• FIGURE 42 LIVE CELL IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
• FIGURE 43 DANAHER: COMPANY SNAPSHOT (2024)
• FIGURE 44 ZEISS GROUP: COMPANY SNAPSHOT (2024)
• FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
• FIGURE 46 REVVITY: COMPANY SNAPSHOT (2024)
• FIGURE 47 SARTORIUS AG: COMPANY SNAPSHOT (2024)
• FIGURE 48 NIKON CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 49 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 50 BRUKER: COMPANY SNAPSHOT (2024)
• FIGURE 51 BD: COMPANY SNAPSHOT (2024)
• FIGURE 52 MERCK KGAA: COMPANY SNAPSHOT (2024)
• FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
• FIGURE 54 TECAN TRADING AG: COMPANY SNAPSHOT (2024)
• FIGURE 55 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 56 CORNING INCORPORATED: COMPANY SNAPSHOT (2024)

The global live cell imaging market is projected to reach USD 4.75 billion in 2030 from USD 3.13 billion in 2025, growing at a CAGR of 8.68% during the forecast period. Ongoing advancements in imaging technologies, along with the rising cancer cases in the world, are factors supporting the growth of the market. Moreover, the availability of funds and grants for cellular biology research and the growing adoption of HCS techniques for drug discovery and research is increasing the demand for live cell imaging products and consumables, supporting the growth of the market. Key players are expanding their reach in emerging markets to grab new growth opportunities in the field of live cell imaging; however, this expansion is restricted due to the high cost of live cell imaging instruments, making these products inaccessible to small academic institutes and pharmaceutical companies.

The market for live cell imaging and analysis software is expected to witness the highest growth within the offerings segment during the forecast period.

The live cell imaging software market is expected to witness the highest growth during the forecast period within the offering segment. This high growth can be attributed to the growing demand for advanced data analysis, automation, and AI integration in cellular research. As imaging technologies become more advanced, researchers require powerful software tools to manage large volumes of complex image data, perform real-time analysis, and extract meaningful biological insights. The growing adoption of high-content screening, 3D imaging, and time-lapse microscopy further fuels the need for intelligent software capable of handling multi-dimensional datasets. In addition, the integration of machine learning and deep learning algorithms into imaging software is enabling faster and more accurate cell segmentation, tracking, and phenotyping, making these tools essential in drug discovery, cancer research, and regenerative medicine.

The pharmaceutical & biotechnology companies end user segment held the largest market share in the live cell imaging market, by end user, during the forecast period.

Pharmaceutical & biotechnology companies held the largest share of the live cell imaging market by end users in 2024. This large share can be attributed to the increasing demand for advanced imaging technologies in drug discovery, cell biology research, and personalized medicine. These companies heavily rely on live cell imaging to observe cellular behaviors, study disease mechanisms, and evaluate the effects of potential drug candidates in real time. The rise in the prevalence of chronic diseases and the growing need for precise therapies further fuel the adoption of live cell imaging technologies in these sectors. This trend is expected to continue during the forecast period of 2025-2030, driven by ongoing innovations in imaging technologies, the need for faster and more accurate drug development, and the growing importance of cellular research in therapeutic development.

Asia Pacific is expected to be the fastest-growing region in the live cell imaging market.

Asia Pacific is the fastest-growing region in the live cell imaging market, having the highest CAGR during the forecast period of 2025-2030. This growth is driven by increased investment in the healthcare and biotechnology sectors, along with the rising demand for advanced imaging technologies. China, Japan, and India are increasing their research and development activities, particularly in drug discovery and regenerative medicine, which require advanced imaging techniques. Additionally, government support for scientific research and the expanding focus on personalized medicine are key factors fueling this market growth in the region.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1- 44%, Tier 2- 32%, and Tier 3- 24%
• By Designation: (Managers)- 45%, (CXOs, Directors)- 30%, and (Executives)- 25%
• By Region: North America- 40%, Europe- 25%, Asia Pacific- 20%, Rest of the World- 15%

List of Companies Profiled in the Report:

• Danaher (US)
• Zeiss Group (Germany)
• Nikon Corporation (Japan)
• Evident (Japan)
• Revvity (US)
• Sartorius AG (Germany)
• Agilent Technologies, Inc. (US)
• Thermo Fisher Scientific Inc. (US)
• Nanoentek (Korea)
• Bruker (US)
• BD (US)
• Merck KGaA (Germany)
• Bio-Rad Laboratories, Inc. (US)
• Tecan Trading AG (Switzerland)
• Corning Incorporated (US)
• Sysmex Corporation (Japan)
• Blue-Ray Biotech Corp. (Taiwan)
• Curiosis Inc. (South Korea)
• CYTENA GmbH (Germany)
• Abberior Instruments America LLC (Germany)
• Phase Holographic Imaging PHI AB (Sweden)
• Aligned Genetics (South Korea)
• Cherry Biotech (France)
• Nanolive SA (Switzerland)
• CytoTronics (US)
• Etaluma, Inc. (US)
• Axion BioSystems, Inc (US)
• TissueGnostics GmbH (Austria)

Research Coverage:

This report provides a detailed picture of the global live cell imaging market. It aims to estimate the size and future growth potential of the market across different segments such as the offering, technology, application, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the live cell imaging market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services, key strategies, partnerships, agreements, product and service launches, mergers and acquisitions, and recent developments associated with the live cell imaging market. Competitive analysis of upcoming startups in the live cell imaging market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall live cell imaging market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, Growing availability of funds for research, advancement in imaging technology), restraints (High cost of high-content screening systems), opportunities (increasing adoption of live cell imaging technologies in emerging markets, and application of HCS in personalized medicine), and challenges (maintaining cell viability and cellular environment in cell cultures, and image analysis and data management) influencing the growth of the live cell imaging market
• Product Development/Innovation: Detailed insight into newly launched products & services and technological assessment of the live cell imaging market
• Market Development: Comprehensive information about lucrative markets - the report analyses the live cell imaging market across varied regions.
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the live cell imaging market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products and service offerings of leading players Danaher (US), Zeiss Group (Germany), Nikon Corporation (Japan), Evident (Japan), Revvity (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), Nanoentek (Korea), Bruker (US), BD (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Tecan Trading AG (Switzerland), Corning Incorporated (US), Sysmex Corporation (Japan), Blue-Ray Biotech Corp. (Taiwan), Curiosis Inc. (South Korea), CYTENA GmbH (Germany), Abberior Instruments America LLC (Germany), Phase Holographic Imaging PHI AB (Sweden), Aligned Genetics (South Korea), Cherry Biotech (France), Nanolive SA (Switzerland), CytoTronics (US), Etaluma, Inc. (US), Axion BioSystems, Inc (US), and TissueGnostics GmbH (Austria) among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONS COVERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 INSIGHTS FROM PRIMARIES
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 GROWTH RATE FORECAST
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 LIVE CELL IMAGING MARKET OVERVIEW
• 4.2 NORTH AMERICA: LIVE CELL IMAGING MARKET, BY OFFERING AND COUNTRY, 2024
• 4.3 LIVE CELL IMAGING MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
• 4.4 LIVE CELL IMAGING MARKET, BY END USER, 2024
• 4.5 LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing adoption of high-content screening techniques in drug discovery
    • 5.2.1.2 Rising incidence of cancer
    • 5.2.1.3 Growing availability of research funds
    • 5.2.1.4 Advancements in imaging technology
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Expensive high-content screening systems
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing adoption of live cell imaging technologies in emerging markets
    • 5.2.3.2 Growing applications of live cell imaging in personalized medicine
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Maintenance of cell viability and cellular environment in cell cultures
    • 5.2.4.2 Image analysis and data management
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.4 PRICING ANALYSIS
  • 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.4.2 AVERAGE SELLING PRICE, BY REGION
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 INVESTMENT AND FUNDING ACTIVITY
• 5.8 TECHNOLOGY ANALYSIS
  • 5.8.1 KEY TECHNOLOGIES
    • 5.8.1.1 Fluorescence microscopy
    • 5.8.1.2 Confocal microscopy
    • 5.8.1.3 Super-resolution microscopy
    • 5.8.1.4 Forster resonance energy transfer
    • 5.8.1.5 Fluorescence recovery after photobleaching
  • 5.8.2 COMPLEMENTARY TECHNOLOGIES
    • 5.8.2.1 Image analysis software
    • 5.8.2.2 Microfluidics
    • 5.8.2.3 Optogenetics
    • 5.8.2.4 Multiphoton microscopy
  • 5.8.3 ADJACENT TECHNOLOGIES
    • 5.8.3.1 Fixed cell imaging
• 5.9 PATENT ANALYSIS
• 5.10 TRADE DATA ANALYSIS
  • 5.10.1 IMPORT DATA FOR HS CODE 901120
  • 5.10.2 EXPORT DATA FOR HS CODE 901120
• 5.11 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.12 REGULATORY LANDSCAPE
  • 5.12.1 REGULATORY FRAMEWORK
    • 5.12.1.1 North America
      • 5.12.1.1.1 US
      • 5.12.1.1.2 Canada
    • 5.12.1.2 Europe
      • 5.12.1.2.1 UK
      • 5.12.1.2.2 European Union
    • 5.12.1.3 Asia Pacific
      • 5.12.1.3.1 Japan
      • 5.12.1.3.2 South Korea
      • 5.12.1.3.3 China
  • 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.13 PORTER'S FIVE FORCES ANALYSIS
  • 5.13.1 THREAT FROM NEW ENTRANTS
  • 5.13.2 THREAT FROM SUBSTITUTES
  • 5.13.3 BARGAINING POWER OF SUPPLIERS
  • 5.13.4 BARGAINING POWER OF BUYERS
  • 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.14.2 BUYING CRITERIA
• 5.15 IMPACT OF AI/GENERATIVE AI ON LIVE CELL IMAGING MARKET
  • 5.15.1 INTRODUCTION
  • 5.15.2 KEY COMPANIES IMPLEMENTING AI
  • 5.15.3 AI USE CASES
  • 5.15.4 FUTURE OF AI IN LIVE CELL IMAGING ECOSYSTEM
• 5.16 IMPACT OF 2025 US TARIFF ON LIVE CELL IMAGING MARKET
  • 5.16.1 INTRODUCTION
  • 5.16.2 KEY TARIFF RATES
  • 5.16.3 PRICE IMPACT ANALYSIS
  • 5.16.4 IMPACT ON COUNTRY/REGION
    • 5.16.4.1 US
    • 5.16.4.2 Europe
    • 5.16.4.3 Asia Pacific
  • 5.16.5 IMPACT ON END-USE INDUSTRIES
    • 5.16.5.1 Pharmaceutical & biotech companies
    • 5.16.5.2 Academic & research institutes
    • 5.16.5.3 Contract research organizations

6 LIVE CELL IMAGING MARKET, BY OFFERING

• 6.1 INTRODUCTION
• 6.2 PRODUCTS
  • 6.2.1 INSTRUMENTS
    • 6.2.1.1 Microscopes
      • 6.2.1.1.1 Ongoing technological advancements in microscopes to support growth
    • 6.2.1.2 Cell imaging systems
      • 6.2.1.2.1 Seamless integration and workflow efficiency of standalone systems to boost market
    • 6.2.1.3 Cell analyzers
      • 6.2.1.3.1 Accuracy and reproducibility of cell analyzers to encourage growth
    • 6.2.1.4 Accessories
      • 6.2.1.4.1 Increasing demand for live cell imaging in life science research to accelerate growth
  • 6.2.2 CONSUMABLES
    • 6.2.2.1 Reagents
      • 6.2.2.1.1 Widespread usage of reagents in life science research to foster growth
    • 6.2.2.2 Assay kits
      • 6.2.2.2.1 Higher customer convenience and time-saving solutions to amplify growth
    • 6.2.2.3 Media
      • 6.2.2.3.1 Increasing investments in cell-based research to intensify growth
    • 6.2.2.4 Other consumables
• 6.3 SOFTWARE
  • 6.3.1 INCREASING ADVANCEMENTS IN IMAGE ACQUISITION TO SUPPORT GROWTH
• 6.4 SERVICES
  • 6.4.1 GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO FUEL MARKET

7 LIVE CELL IMAGING MARKET, BY TECHNOLOGY

• 7.1 INTRODUCTION
• 7.2 TIME-LAPSE MICROSCOPY
  • 7.2.1 GROWING DEMAND FOR HIGH CONTENT AND HIGH THROUGHPUT ANALYSIS IN PRECLINICAL STUDIES TO DRIVE MARKET
• 7.3 FLUORESCENCE RESONANCE ENERGY TRANSFER
  • 7.3.1 ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST MARKET
• 7.4 FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING
  • 7.4.1 INCREASING ADVANCEMENTS IN FLUORESCENT PROTEINS TO SPUR GROWTH
• 7.5 HIGH-CONTENT SCREENING
  • 7.5.1 GROWING FOCUS ON DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE MARKET
• 7.6 OTHER TECHNOLOGIES

8 LIVE CELL IMAGING MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 CELL BIOLOGY RESEARCH
  • 8.2.1 INCREASING FOCUS ON DISEASE RESEARCH TO SUPPORT GROWTH
• 8.3 DRUG DISCOVERY
  • 8.3.1 GROWING USE OF HIGH-CONTENT SCREENING CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO BOOST MARKET
• 8.4 STEM CELL RESEARCH
  • 8.4.1 INCREASING FOCUS ON REGENERATIVE MEDICINE TO EXPEDITE GROWTH
• 8.5 DEVELOPMENTAL BIOLOGY
  • 8.5.1 RISING INTEREST IN ORGANOGENESIS AND TISSUE MORPHOGENESIS TO PROMOTE GROWTH

9 LIVE CELL IMAGING MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.2.1 INCREASING R&D ACTIVITIES TO DEVELOP NEW DRUGS TO SUPPORT GROWTH
• 9.3 ACADEMIC & RESEARCH INSTITUTES
  • 9.3.1 RISING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO AID GROWTH
• 9.4 CONTRACT RESEARCH ORGANIZATIONS
  • 9.4.1 GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE MARKET

10 LIVE CELL IMAGING MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC ANALYSIS FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Presence of major players and increasing investments in life science research to sustain growth
  • 10.2.3 CANADA
    • 10.2.3.1 Government initiatives to promote research to aid growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC ANALYSIS FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Presence of large number of academic research institutes to boost market
  • 10.3.3 UK
    • 10.3.3.1 Investments by pharmaceutical sponsors for drug discovery services to foster market
  • 10.3.4 FRANCE
    • 10.3.4.1 Booming pharmaceutical manufacturing industry to drive market growth
  • 10.3.5 ITALY
    • 10.3.5.1 Strong research tradition, government funding, and collaborative research networks to fuel growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Rising R&D expenditure to boost market
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC ANALYSIS FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Low manufacturing cost and surge in research & development investments to spur growth
  • 10.4.3 JAPAN
    • 10.4.3.1 Presence of large geriatric population and increasing research activities to bolster growth
  • 10.4.4 INDIA
    • 10.4.4.1 Growing pharmaceutical industry to propel market
  • 10.4.5 SOUTH KOREA
    • 10.4.5.1 Ongoing collaborations and research initiatives among market players to encourage growth
  • 10.4.6 AUSTRALIA
    • 10.4.6.1 Robust healthcare infrastructure to facilitate growth
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC ANALYSIS FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Growing focus on biotechnology and biomedical innovations to drive market
  • 10.5.3 MEXICO
    • 10.5.3.1 Low manufacturing cost and large population to support growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST
  • 10.6.1 MACROECONOMIC ANALYSIS FOR MIDDLE EAST
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Saudi Arabia
      • 10.6.2.1.1 Increasing life science research funding to aid growth
    • 10.6.2.2 UAE
      • 10.6.2.2.1 Presence of research institutes supporting live cell imaging studies to foster growth
    • 10.6.2.3 Rest of GCC Countries
  • 10.6.3 REST OF MIDDLE EAST
• 10.7 AFRICA
  • 10.7.1 GOVERNMENT INITIATIVES TO CONTRIBUTE TO GROWTH
  • 10.7.2 MACROECONOMIC ANALYSIS FOR AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LIVE CELL IMAGING MARKET
• 11.3 REVENUE ANALYSIS, 2022-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 COMPANY VALUATION AND FINANCIAL METRICS
• 11.6 BRAND/PRODUCT COMPARISON
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
• 11.8 COMPANY FOOTPRINT, KEY PLAYERS, 2024
  • 11.8.1 COMPANY FOOTPRINT
  • 11.8.2 REGION FOOTPRINT
  • 11.8.3 OFFERING FOOTPRINT
  • 11.8.4 APPLICATION FOOTPRINT
• 11.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.9.1 PROGRESSIVE COMPANIES
  • 11.9.2 RESPONSIVE COMPANIES
  • 11.9.3 DYNAMIC COMPANIES
  • 11.9.4 STARTING BLOCKS
• 11.10 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  • 11.10.1 DETAILED LIST OF KEY STARTUPS/SMES
  • 11.10.2 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
• 11.11 COMPETITIVE SCENARIO
  • 11.11.1 PRODUCT LAUNCHES AND UPGRADES
  • 11.11.2 DEALS
  • 11.11.3 EXPANSIONS

12 COMPANY PROFILE

• 12.1 KEY PLAYERS
  • 12.1.1 DANAHER
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches and upgrades
      • 12.1.1.3.2 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 ZEISS GROUP
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches and upgrades
      • 12.1.2.3.2 Deals
      • 12.1.2.3.3 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 THERMO FISHER SCIENTIFIC INC.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 REVVITY
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches and upgrades
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses and competitive threats
  • 12.1.5 SARTORIUS AG
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strength
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses and competitive threats
  • 12.1.6 NIKON CORPORATION
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Expansions
  • 12.1.7 EVIDENT
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches and upgrades
  • 12.1.8 AGILENT TECHNOLOGIES, INC.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product launches and upgrades
  • 12.1.9 NANOENTEK
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
  • 12.1.10 BRUKER
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Deals
  • 12.1.11 BD
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
  • 12.1.12 MERCK KGAA
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
  • 12.1.13 BIO-RAD LABORATORIES, INC.
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
  • 12.1.14 TECAN TRADING AG
    • 12.1.14.1 Business overview
  • 12.1.15 SYSMEX CORPORATION
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
  • 12.1.16 CORNING INCORPORATED
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 AXION BIOSYSTEMS, INC.
  • 12.2.2 BLUE-RAY BIOTECH CORP.
  • 12.2.3 CURIOSIS INC.
  • 12.2.4 CYTENA GMBH
  • 12.2.5 ABBERIOR GMBH
  • 12.2.6 PHASE HOLOGRAPHIC IMAGING PHI AB
  • 12.2.7 ALIGNED GENETICS INC.
  • 12.2.8 CHERRY BIOTECH
  • 12.2.9 NANOLIVE SA
  • 12.2.10 CYTOTRONICS
  • 12.2.11 ETALUMA, INC.
  • 12.2.12 TISSUEGNOSTICS GMBH

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS